abstract |
ThenThe present invention relates to a pharmaceutical composition as an active ingredient combinationnat least one contraceptive gestagen as the only hormone componentnand at least one insulin sensitiser, which is in particular fornProphylaxis against or treatment of pathological disorders,nwhich are caused by the polycystic ovary syndrome (PCOS) is suitable. |